TD Asset Management »

Oric Pharmaceuticals shares owned by TD Asset Management

Quarter-by-quarter ownership of Oric Pharmaceuticals (ORIC) shares owned by TD Asset Management from 13F filings

Historical chart of TD Asset Management investment in Oric Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Oric Pharmaceuticals held by TD Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oric Pharmaceuticals by TD Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $743k 81k 9.20

More positions owned by TD Asset Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Apple (AAPL)
Rbc Cad (RY)
Toronto Dominion Bk Ont Com New (TD)
Bank Of Montreal Cadcom (BMO)
NVIDIA Corporation (NVDA)
Canadian Pacific Kansas City (CP)
UnitedHealth (UNH)
Canadian Natl Ry (CNI)
Amazon (AMZN)
Visa Com Cl A (V)
Canadian Natural Resources (CNQ)
Enbridge (ENB)
Eli Lilly & Co. (LLY)

View all positions for TD Asset Management

Top funds holding Oric Pharmaceuticals

Nextech Invest
Column Group
EcoR1 Capital
VR Adviser
Vanguard Group
Frazier Life Sciences Management
Arrowpoint Asset Management
Boxer Capital
Invus Financial Advisors
Euclidean Capital
Vivo Capital
Franklin Resources
Henderson Group
T. Rowe Price Associates
OrbiMed Advisors

View all funds holding Oric Pharmaceuticals